518.00
0.00
(0.00%)
As of April 14 at 1:48:43 PM GMT+1. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 21 | 21 | 29 | 29 |
Avg. Estimate | 7.56B | 3.52B | 18.37B | 20.63B |
Low Estimate | 7.45B | 3.4B | 18.13B | 20.28B |
High Estimate | 7.62B | 3.68B | 19.08B | 21.43B |
Year Ago Sales | 6.74B | 3.18B | 16.29B | 18.37B |
Sales Growth (year/est) | 12.23% | 10.41% | 12.82% | 12.28% |
EPS Trend
Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
ITUD.XC | -- | -- | -- | -- |
S&P 500 | 6.79% | 5.59% | 9.06% | 14.11% |
Upgrades & Downgrades
Maintains | Morgan Stanley: Overweight to Overweight | 4/16/2025 |
Maintains | Oppenheimer: Outperform to Outperform | 4/11/2025 |
Maintains | Jefferies: Buy to Buy | 3/31/2025 |
Upgrade | JP Morgan: Neutral to Overweight | 3/5/2025 |
Maintains | Mizuho: Outperform to Outperform | 3/3/2025 |
Maintains | Scotiabank: Sector Perform to Sector Perform | 2/27/2025 |